Oppenheimer cut Sutro to Perform, says ‘not too surprised’ with restructuring
PremiumThe FlyOppenheimer cut Sutro to Perform, says ‘not too surprised’ with restructuring
22d ago
Sutro Biopharma downgraded to Perform from Outperform at Oppenheimer
Premium
The Fly
Sutro Biopharma downgraded to Perform from Outperform at Oppenheimer
22d ago
Buy/Sell: Wall Street’s top 10 stock calls this week
Premium
The Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
22d ago
Cautious Hold Rating on Sutro Biopharma Amid Strategic Shift and Restructuring
PremiumRatingsCautious Hold Rating on Sutro Biopharma Amid Strategic Shift and Restructuring
22d ago
Sutro Biopharma’s Strategic Shift: Hold Rating Amid Reprioritization and Financial Restructuring
Premium
Ratings
Sutro Biopharma’s Strategic Shift: Hold Rating Amid Reprioritization and Financial Restructuring
22d ago
Sutro Biopharma downgraded to Neutral from Outperform at Wedbush
Premium
The Fly
Sutro Biopharma downgraded to Neutral from Outperform at Wedbush
22d ago
Sutro Biopharma price target lowered to $4 from $5 at Wells Fargo
PremiumThe FlySutro Biopharma price target lowered to $4 from $5 at Wells Fargo
4M ago
Sutro Biopharma announces selected doses from REFRalphaME-O1
Premium
The Fly
Sutro Biopharma announces selected doses from REFRalphaME-O1
4M ago
Sutro Biopharma Advances Pipeline Amid Financial Losses
Premium
Company Announcements
Sutro Biopharma Advances Pipeline Amid Financial Losses
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100